Qualigen Therapeutics, Inc. — Director's Dealing 2016

Dec 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2016-11-29

Reporting Person: FOEHR MATTHEW W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-29	Stock Option (2015 Equity Incentive Plan)	$2.37	A	7000	Acquired	2026-11-29	Common Stock (7000)	Direct

Footnotes

F1: Of the 7,000 shares granted, 730 shares were vested as of the grant date and the remaining 6,270 shares will vest ratably over the next 43 months.